Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 23, 2023
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
[ Thu, Feb 23rd 2023
] - WOPRAI
Mike Matson Maintained (VCYT) at Strong Buy with Increased Target to $34 on, Feb 23rd, 2023
Mike Matson of Needham, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Increased Target from $33 to $34 on, Feb 23rd, 2023.
Mike has made no other calls on VCYT in the last 4 months.
There are 4 other peers that have a rating on VCYT. Out of the 4 peers that are also analyzing VCYT, 1 agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Wednesday, January 18th, 2023
These are the ratings of the 3 analyists that currently disagree with Mike
- Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $33 on, Thursday, January 5th, 2023
- Tejas Savant of "Morgan Stanley" Maintained at Sell with Decreased Target to $22 on, Friday, November 4th, 2022
- Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $35 on, Thursday, November 3rd, 2022
